Clinical trial
Peginesatide for Anemia in Chronic Hemodialysis Patients
NCT00228449 · Affymax, Industry · Completed
Key facts
| NCT number | NCT00228449 |
|---|---|
| Title | Peginesatide for Anemia in Chronic Hemodialysis Patients |
| Official title | A Phase 2, Open-label, Multi-center, Sequential, Dose Finding Study of the Safety, Pharmacodynamics, and Pharmacokinetics of Peginesatide Administered Intravenously for the Maintenance Treatment of Anemia in Chronic Hemodialysis Patients |
| Lead sponsor | Affymax, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Kidney Disease, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | peginesatide |
| Enrollment | 165 |
| Start date | Jul 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Dec 21, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: